Combining Immunotherapy with Transarterial Radioembolization

Zeynep Ceren Balaban Genc1, Efe Soydemır2, Seval Ay Ersoy3

  • 1Department of Nuclear Medicine, Pendik Training and Research Hospital, Marmara University, Istanbul, Turkey.

Summary

This case report shows that combining transarterial radioembolization with immunotherapy (atezolizumab and bevacizumab) is an effective treatment strategy for advanced hepatocellular carcinoma (HCC). This combination offers a promising approach for managing this challenging cancer.

Related Concept Videos